Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Frank Scott

Concepts (321)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Inflammatory Bowel Diseases
27
2025
351
8.060
Why?
Crohn Disease
14
2025
243
4.260
Why?
Colitis, Ulcerative
9
2025
136
2.160
Why?
Gastrointestinal Agents
5
2024
65
1.640
Why?
Infliximab
10
2022
111
1.590
Why?
Intestinal Obstruction
3
2021
51
1.510
Why?
Gastroenterology
6
2024
180
1.390
Why?
Tissue Adhesions
3
2021
32
1.290
Why?
Immunosuppressive Agents
6
2020
890
1.280
Why?
Tumor Necrosis Factor-alpha
10
2023
1242
1.130
Why?
Adrenal Cortex Hormones
4
2022
565
1.110
Why?
Antibodies, Monoclonal, Humanized
4
2024
804
0.990
Why?
Intestine, Small
2
2021
156
0.990
Why?
Algorithms
6
2020
1704
0.910
Why?
JC Virus
2
2015
23
0.900
Why?
Leukoencephalopathy, Progressive Multifocal
2
2015
37
0.880
Why?
Azathioprine
5
2021
54
0.830
Why?
Bone Diseases, Metabolic
1
2023
63
0.810
Why?
Abdomen
2
2021
125
0.780
Why?
Esophageal Neoplasms
6
2022
321
0.770
Why?
Abdominal Abscess
1
2022
27
0.770
Why?
Biological Products
3
2023
216
0.760
Why?
Humans
88
2025
137585
0.750
Why?
Postoperative Complications
3
2021
2654
0.720
Why?
Gastrointestinal Hemorrhage
3
2023
132
0.710
Why?
Anti-Bacterial Agents
5
2018
1809
0.680
Why?
Ustekinumab
1
2020
15
0.680
Why?
Splints
1
2020
15
0.680
Why?
Capsule Endoscopy
1
2020
18
0.670
Why?
Antibodies, Viral
2
2015
625
0.670
Why?
Biosimilar Pharmaceuticals
1
2020
23
0.660
Why?
Barrett Esophagus
4
2023
149
0.640
Why?
Radius Fractures
1
2020
59
0.640
Why?
Biomedical Research
2
2019
692
0.630
Why?
Retrospective Studies
26
2023
15657
0.630
Why?
Quality-Adjusted Life Years
5
2021
113
0.600
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2021
445
0.600
Why?
Spondylarthritis
3
2025
50
0.600
Why?
Colonoscopy
7
2024
245
0.590
Why?
Drug Utilization
1
2019
169
0.580
Why?
Intestinal Fistula
1
2018
17
0.570
Why?
Surgical Procedures, Operative
1
2021
259
0.570
Why?
Health Resources
1
2019
120
0.570
Why?
Colonic Diseases
1
2018
33
0.570
Why?
Pericardium
1
2018
55
0.560
Why?
Tuberculin Test
1
2017
36
0.560
Why?
Cost-Benefit Analysis
5
2021
591
0.560
Why?
Biological Factors
2
2023
39
0.540
Why?
Epstein-Barr Virus Infections
1
2018
98
0.540
Why?
Models, Statistical
2
2019
669
0.540
Why?
Latent Tuberculosis
1
2017
69
0.520
Why?
Time-to-Treatment
2
2019
205
0.520
Why?
Mass Screening
4
2021
1287
0.520
Why?
Colorectal Neoplasms
6
2024
806
0.510
Why?
Male
47
2025
67762
0.500
Why?
Adult
35
2025
37929
0.490
Why?
Antibodies, Monoclonal
4
2021
1430
0.490
Why?
Middle Aged
36
2025
33479
0.480
Why?
Radius
1
2015
39
0.470
Why?
Natalizumab
1
2015
40
0.470
Why?
Hospitalization
3
2022
2199
0.460
Why?
Heart Diseases
1
2018
346
0.450
Why?
Fracture Fixation
1
2015
75
0.450
Why?
Mycobacterium tuberculosis
1
2017
314
0.440
Why?
Models, Theoretical
1
2018
578
0.430
Why?
Age Factors
5
2025
3295
0.430
Why?
Practice Patterns, Physicians'
3
2024
1313
0.420
Why?
Aged
27
2024
23961
0.420
Why?
Severity of Illness Index
7
2024
2828
0.410
Why?
Markov Chains
3
2020
126
0.400
Why?
Lymphoma
1
2014
208
0.400
Why?
Female
43
2025
73304
0.400
Why?
Risk Factors
17
2025
10388
0.390
Why?
Patient Acceptance of Health Care
4
2024
806
0.390
Why?
Drug Therapy, Combination
4
2024
1066
0.380
Why?
Adalimumab
3
2021
48
0.380
Why?
Communicable Diseases
1
2014
159
0.380
Why?
Patient Discharge
2
2023
897
0.370
Why?
United Kingdom
5
2021
318
0.360
Why?
Gastroenterologists
2
2022
18
0.360
Why?
Professional Competence
1
2012
100
0.360
Why?
Disease Management
3
2021
628
0.350
Why?
Cohort Studies
10
2025
5742
0.340
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2013
350
0.340
Why?
Spondylitis, Ankylosing
2
2021
46
0.340
Why?
Fractures, Bone
1
2015
380
0.330
Why?
Carcinoma, Squamous Cell
1
2016
683
0.330
Why?
Research Design
2
2019
1139
0.330
Why?
Gastroesophageal Reflux
2
2023
234
0.330
Why?
Research Personnel
1
2012
173
0.330
Why?
Treatment Outcome
12
2024
10811
0.330
Why?
Colonic Polyps
2
2024
88
0.320
Why?
Adenoma
3
2024
230
0.320
Why?
United States
17
2025
14841
0.320
Why?
Proportional Hazards Models
5
2021
1266
0.310
Why?
Urinary Bladder Neoplasms
3
2017
252
0.300
Why?
Pediatric Obesity
1
2016
601
0.300
Why?
Skin Neoplasms
1
2016
855
0.290
Why?
Quality of Life
2
2021
2892
0.280
Why?
Electronic Health Records
6
2022
1069
0.280
Why?
Incidence
8
2021
2804
0.280
Why?
Remission Induction
2
2024
288
0.270
Why?
Databases, Factual
7
2018
1357
0.260
Why?
Mortality
2
2020
362
0.260
Why?
Neoplasm Recurrence, Local
3
2017
1079
0.250
Why?
Radiography
2
2020
822
0.240
Why?
Referral and Consultation
2
2023
786
0.240
Why?
Population Surveillance
2
2021
482
0.240
Why?
Antifungal Agents
2
2016
136
0.230
Why?
Aged, 80 and over
10
2020
7635
0.230
Why?
Case-Control Studies
8
2021
3556
0.220
Why?
Recurrence
5
2021
1060
0.220
Why?
Esophageal Stenosis
2
2014
54
0.210
Why?
Delivery of Health Care
2
2021
951
0.210
Why?
Surveys and Questionnaires
8
2025
5778
0.210
Why?
Gastrointestinal Microbiome
2
2022
697
0.210
Why?
Adenocarcinoma
2
2021
940
0.210
Why?
Diagnosis, Computer-Assisted
1
2024
89
0.210
Why?
Obesity
1
2017
2992
0.210
Why?
Colectomy
2
2021
100
0.200
Why?
Esophagitis, Peptic
1
2023
15
0.200
Why?
Protective Factors
2
2021
93
0.200
Why?
Models, Economic
2
2020
58
0.200
Why?
Absorptiometry, Photon
1
2023
259
0.200
Why?
Logistic Models
6
2018
2074
0.200
Why?
Glucocorticoids
2
2018
594
0.200
Why?
Comparative Effectiveness Research
2
2024
152
0.190
Why?
Prognosis
4
2019
4030
0.190
Why?
Cellulitis
1
2022
53
0.190
Why?
Medical Marijuana
1
2024
117
0.190
Why?
Odds Ratio
4
2018
1070
0.190
Why?
Insurance, Health
1
2024
283
0.180
Why?
Necrosis
1
2022
246
0.180
Why?
Amputation, Traumatic
1
2021
20
0.180
Why?
Finger Injuries
1
2021
23
0.180
Why?
Vascular Surgical Procedures
2
2021
303
0.180
Why?
Rectal Fistula
1
2021
28
0.180
Why?
Pancreatic Neoplasms
2
2021
938
0.180
Why?
Aftercare
1
2023
208
0.170
Why?
Prevalence
4
2025
2734
0.170
Why?
Follow-Up Studies
4
2021
5131
0.170
Why?
Liver Transplantation
2
2021
871
0.170
Why?
Artificial Intelligence
1
2024
279
0.170
Why?
Gynecologic Surgical Procedures
1
2021
63
0.170
Why?
Feces
2
2022
484
0.170
Why?
Esophagoscopy
2
2022
209
0.170
Why?
Cystectomy
2
2017
37
0.170
Why?
Leukocyte L1 Antigen Complex
1
2020
32
0.170
Why?
Utilization Review
1
2020
36
0.170
Why?
Sugars
1
2020
41
0.160
Why?
Digestive System Surgical Procedures
1
2021
106
0.160
Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
2020
35
0.160
Why?
Bone Density
1
2023
489
0.160
Why?
Bone Plates
1
2020
77
0.160
Why?
Carcinoma
1
2021
240
0.160
Why?
Diabetes Mellitus
2
2021
1040
0.160
Why?
Urologic Surgical Procedures
1
2021
120
0.160
Why?
Quality Assurance, Health Care
1
2021
322
0.160
Why?
Tryptophan
1
2021
183
0.160
Why?
Metagenomics
1
2021
169
0.160
Why?
Sensitivity and Specificity
1
2024
1946
0.150
Why?
Hospitals
2
2021
691
0.150
Why?
Deglutition Disorders
1
2021
143
0.150
Why?
Hospitals, Veterans
1
2020
252
0.150
Why?
Obesity, Morbid
1
2023
264
0.150
Why?
Chronic Disease
2
2022
1793
0.150
Why?
Child
6
2023
21935
0.150
Why?
Metabolomics
2
2022
678
0.150
Why?
Diverticulum
1
2018
12
0.150
Why?
Job Satisfaction
1
2021
218
0.150
Why?
Hematemesis
1
2018
3
0.150
Why?
Health Care Costs
1
2021
398
0.140
Why?
Infant
5
2020
9465
0.140
Why?
Carcinoma, Pancreatic Ductal
1
2021
289
0.140
Why?
Fracture Fixation, Internal
1
2020
188
0.140
Why?
Symptom Assessment
2
2017
128
0.140
Why?
Range of Motion, Articular
1
2020
393
0.140
Why?
Intestines
1
2021
357
0.140
Why?
Endoscopic Mucosal Resection
1
2017
25
0.140
Why?
Ambulatory Care
1
2021
546
0.140
Why?
Clostridium Infections
1
2018
73
0.140
Why?
Fatal Outcome
1
2018
303
0.130
Why?
Arthritis, Rheumatoid
2
2016
1167
0.130
Why?
Risk Assessment
3
2016
3457
0.130
Why?
Quality of Health Care
1
2021
642
0.130
Why?
Cystadenoma, Mucinous
1
2016
13
0.130
Why?
Continuity of Patient Care
1
2019
284
0.130
Why?
Randomized Controlled Trials as Topic
2
2024
1477
0.130
Why?
Itraconazole
1
2016
6
0.130
Why?
Budesonide
1
2016
89
0.120
Why?
Pharmacoepidemiology
1
2015
19
0.120
Why?
Carcinoma, Intraductal, Noninfiltrating
1
2016
56
0.120
Why?
Analgesics, Opioid
1
2024
1000
0.120
Why?
Endoscopy, Gastrointestinal
3
2023
228
0.120
Why?
Pancreatic Diseases
1
2016
72
0.120
Why?
Guideline Adherence
1
2020
556
0.120
Why?
Cross-Sectional Studies
4
2025
5472
0.120
Why?
Cysts
1
2016
113
0.120
Why?
Hyperlipidemias
1
2016
120
0.120
Why?
Epiphyses
1
2015
25
0.120
Why?
Child, Preschool
5
2016
11074
0.120
Why?
Neoplasms, Second Primary
1
2016
118
0.120
Why?
Antirheumatic Agents
1
2018
293
0.120
Why?
Data Accuracy
1
2015
65
0.120
Why?
Societies, Medical
3
2024
820
0.120
Why?
Psoriasis
1
2016
102
0.110
Why?
Arthritis, Juvenile
1
2015
56
0.110
Why?
Polypharmacy
1
2015
85
0.110
Why?
Adolescent
7
2019
21513
0.110
Why?
Neoplasms
2
2023
2671
0.110
Why?
Elbow Joint
1
2015
71
0.110
Why?
Hedgehog Proteins
1
2016
195
0.110
Why?
Prescription Drugs
1
2015
109
0.110
Why?
Interferon-gamma
1
2017
789
0.110
Why?
Young Adult
7
2019
13209
0.110
Why?
Dilatation
1
2014
67
0.110
Why?
Burnout, Professional
1
2021
442
0.110
Why?
Cholesterol
1
2016
410
0.110
Why?
Microbiota
1
2022
762
0.110
Why?
Immunologic Factors
1
2016
236
0.110
Why?
Anastomosis, Surgical
1
2014
153
0.110
Why?
Streptococcal Infections
1
2016
151
0.110
Why?
Virus Diseases
1
2016
212
0.100
Why?
Radiation Injuries
1
2014
145
0.100
Why?
Renal Insufficiency, Chronic
1
2019
617
0.100
Why?
Foreign Bodies
1
2014
104
0.100
Why?
Disease Progression
2
2021
2757
0.100
Why?
Registries
1
2021
2035
0.100
Why?
Early Detection of Cancer
3
2022
447
0.100
Why?
Reoperation
1
2015
573
0.100
Why?
Primary Health Care
2
2022
1738
0.090
Why?
Physical Therapy Modalities
1
2015
308
0.090
Why?
Diabetes Complications
1
2013
227
0.090
Why?
Epidemiology
1
2012
33
0.090
Why?
Patient Readmission
1
2017
697
0.090
Why?
Tissue and Organ Procurement
1
2015
321
0.090
Why?
Endoscopy
1
2014
318
0.090
Why?
Biomarkers
2
2020
4149
0.090
Why?
Research Support as Topic
1
2012
119
0.090
Why?
Age Distribution
1
2012
392
0.090
Why?
Time Factors
5
2021
6828
0.090
Why?
Predictive Value of Tests
1
2016
2031
0.080
Why?
Physicians
1
2019
910
0.080
Why?
Veterans
1
2021
1476
0.080
Why?
Prospective Studies
4
2024
7604
0.080
Why?
Medicare
3
2021
773
0.070
Why?
Drug Prescriptions
2
2024
245
0.070
Why?
Laparoscopy
1
2012
466
0.070
Why?
Emergency Service, Hospital
1
2019
2069
0.070
Why?
Neoplasm Staging
2
2022
1389
0.070
Why?
Academic Medical Centers
2
2021
512
0.060
Why?
Pennsylvania
2
2017
116
0.060
Why?
Kaplan-Meier Estimate
2
2020
889
0.060
Why?
Sex Factors
2
2025
2071
0.060
Why?
Janus Kinase Inhibitors
1
2024
26
0.060
Why?
Breast Neoplasms
1
2016
2253
0.050
Why?
Survival Analysis
2
2017
1325
0.050
Why?
Multivariate Analysis
2
2017
1509
0.050
Why?
Regression Analysis
2
2017
1024
0.050
Why?
Piperidines
1
2024
206
0.050
Why?
Insurance Coverage
1
2024
230
0.050
Why?
Gastrectomy
1
2023
126
0.050
Why?
Consensus
1
2024
683
0.050
Why?
Replantation
1
2021
31
0.040
Why?
Cost Savings
1
2021
84
0.040
Why?
Granzymes
1
2021
50
0.040
Why?
Fingers
1
2021
88
0.040
Why?
Review Literature as Topic
1
2021
75
0.040
Why?
Documentation
1
2023
194
0.040
Why?
Training Support
1
2021
35
0.040
Why?
Salaries and Fringe Benefits
1
2021
56
0.040
Why?
Evidence-Based Medicine
1
2024
740
0.040
Why?
Hand
1
2021
156
0.040
Why?
Morbidity
1
2021
324
0.040
Why?
Metabolic Networks and Pathways
1
2021
180
0.040
Why?
Perception
1
2022
359
0.040
Why?
Reproducibility of Results
2
2019
3284
0.040
Why?
SEER Program
1
2020
227
0.040
Why?
Dysbiosis
1
2021
181
0.040
Why?
Physician's Role
1
2021
211
0.040
Why?
Medicine
1
2021
121
0.040
Why?
Disease Susceptibility
1
2021
347
0.040
Why?
Age of Onset
1
2020
518
0.040
Why?
Career Choice
1
2021
219
0.040
Why?
Delayed Diagnosis
1
2019
91
0.040
Why?
Gene Expression Regulation, Bacterial
1
2021
328
0.040
Why?
Pharmacovigilance
1
2018
23
0.040
Why?
Mathematical Concepts
1
2018
31
0.040
Why?
Decision Support Systems, Clinical
1
2021
226
0.030
Why?
Margins of Excision
1
2017
50
0.030
Why?
Smoking
1
2025
1627
0.030
Why?
Prednisone
1
2018
240
0.030
Why?
Mercaptopurine
1
2016
16
0.030
Why?
Hip Fractures
1
2018
86
0.030
Why?
Etanercept
1
2016
57
0.030
Why?
Longitudinal Studies
1
2024
2844
0.030
Why?
Pilot Projects
1
2022
1710
0.030
Why?
Clinical Competence
1
2024
1118
0.030
Why?
Survival Rate
1
2021
1972
0.030
Why?
Computational Biology
1
2021
644
0.030
Why?
Endoscopic Ultrasound-Guided Fine Needle Aspiration
1
2016
56
0.030
Why?
Decision Making
1
2023
900
0.030
Why?
Glomerular Filtration Rate
1
2019
746
0.030
Why?
Streptococcus pyogenes
1
2016
45
0.030
Why?
Cause of Death
1
2018
434
0.030
Why?
Intestinal Mucosa
1
2021
623
0.030
Why?
Weight Loss
1
2021
787
0.030
Why?
Methotrexate
1
2016
260
0.030
Why?
Statistics, Nonparametric
1
2015
431
0.030
Why?
Bias
1
2016
218
0.030
Why?
Neoplasm Invasiveness
1
2016
510
0.030
Why?
Mental Recall
1
2015
202
0.030
Why?
Computer Simulation
1
2018
978
0.030
Why?
Gene Expression Profiling
1
2021
1774
0.030
Why?
Medicaid
1
2018
435
0.030
Why?
Anticoagulants
1
2018
664
0.030
Why?
Waiting Lists
1
2015
266
0.030
Why?
Practice Guidelines as Topic
1
2021
1587
0.030
Why?
T-Lymphocytes
1
2021
1996
0.020
Why?
Respiratory Tract Infections
1
2015
390
0.020
Why?
Cardiovascular Diseases
1
2018
2111
0.010
Why?
Scott's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)